Studies Do Not Rule Out Cancer Risks Tied to Vytorin
Findings from three studies of the cholesterol drug Vytorin neither confirm nor rule out a potential link to a higher risk of cancer, so the drug should be used with caution, editors of the New England Journal of Medicine write in journal.
- "Medical Journal Says Vytorin Link to Cancer Can't Be Ruled Out" (AP/Los Angeles Times, 9/3).